PharmOptima LLC Scientist Presents Study Poster at ARVO 2013
Mr. Douglas Decker, Vice President, Director of Biochemistry & Cell Biology at PharmOptima, said “...VEGF, VEGF-C, and VEGF-D levels increased significantly in LPS treated eyes of NZW and are indicative of an inflammatory response. Ophthalmic exams, cell counts, and protein increases in LPS treated eyes support increased inflammation in this rabbit model of uveitis. The significantly increased levels of VEGF-C and VEGF-D in AH are new findings.”
The poster can be viewed in detail at the PharmOptima website www.pharmoptima.com.
Mr. Douglas Decker, Vice President, Director of Biochemistry & Cell Biology